Growing implications of glycosylation in physiological occurrences and human disease have
prompted intensive focus on revealing glycomic perturbations through absolute and relative
quantification. Empowered by seminal methodologies and increasing capacity for detection,
identification, and characterization, the past decade has provided a significant increase in
the number of suitable strategies for glycan and glycopeptide quantification. Mass-
spectrometry-based strategies for glycomic quantitation have grown to include metabolic …